Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Details for Australian Patent Application No. 2007286756 (hide)

Owner Allergan, Inc.

Inventors Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2007286756

PCT Pub. Number WO2008/024765

Priority 60/823,297 23.08.06 US

Filing date 21 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/024765 Priority application(s): WO2008/024765

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286780-Method and apparatus for random access in an orthogonal multiple-access communication system

2007286754-Identification and characterization of HCV replicon variants with reduced susceptibility to HCV-796, and methods related thereto